PATENT CLAIM ANALYSIS

Application Number: 16223332
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "192100"]

Abstract:
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of colony stimulating factor 1 receptor (CSF1R) and their use in the treatment of diseases, such as immunotherapies for cancer and/or an inflammatory disease.

Claim (Index 24):
The heterologous chimeric protein of  claim 1 , wherein the linker is a polypeptide selected from a flexible amino acid sequence, an IgG hinge region, or an antibody sequence.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16203469', '15853241', '16024226', '16024209', '16024214']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8194832164057737
- 35 USC 102 Novelty (BERT): 0.5667332390685809
- Combined Prediction Score: 0.7942082186720545
- Mean Citation Score: 470.10808
- Max Citation Score: 485.20197
- Similarity Product: 358.79114638744363

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test